US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 70.100
  • -0.190-0.27%
Close Oct 1 16:00 ET
13.35BMarket Cap53.11P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
23.63%505.34M
Operating revenue
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
23.63%505.34M
Cost of revenue
-0.12%130.46M
-7.60%125.18M
6.45%514.85M
6.43%135.48M
7.27%124.75M
6.09%130.62M
15.82%135.47M
2.80%483.67M
6.30%127.29M
12.32%116.29M
Gross profit
25.16%581.57M
13.60%523.65M
18.11%1.9B
24.49%510.73M
17.36%456.58M
13.15%464.66M
14.55%460.94M
17.20%1.61B
24.29%410.25M
27.47%389.06M
Operating expense
15.54%461.12M
11.71%445.19M
11.48%1.75B
14.35%496.45M
10.37%431.01M
7.68%399.09M
7.40%398.54M
8.02%1.57B
10.11%434.15M
9.52%390.53M
Selling and administrative expenses
27.62%263.03M
7.05%225.91M
9.75%937.3M
11.93%275M
3.32%224M
4.71%206.1M
8.43%211.02M
12.46%854M
12.91%245.7M
18.28%216.8M
-Selling and marketing expense
6.23%122.8M
----
8.46%488.4M
6.90%133.2M
9.52%121.9M
5.67%115.6M
----
11.16%450.3M
10.17%124.6M
14.74%111.3M
-General and administrative expense
54.95%140.23M
----
11.20%448.9M
17.09%141.8M
-3.22%102.1M
3.51%90.5M
----
13.94%403.7M
15.89%121.1M
22.25%105.5M
Research and development costs
3.62%183.79M
19.29%204.99M
14.96%746.77M
19.39%206.25M
21.22%191.31M
12.12%177.36M
6.85%171.85M
3.31%649.61M
7.24%172.75M
-0.03%157.83M
Depreciation amortization depletion
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.18%15.2M
-1.26%15.7M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
3.25%15.9M
-Depreciation and amortization
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.18%15.2M
-1.26%15.7M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
3.25%15.9M
Operating profit
83.71%120.45M
25.73%78.46M
243.96%158.1M
159.74%14.28M
1,835.91%25.57M
63.70%65.57M
99.20%62.4M
161.84%45.96M
62.79%-23.9M
97.13%-1.47M
Net non-operating interest income expense
83.03%16.21M
91.97%15.82M
1,886.63%41M
134.97%11.95M
3,637.81%11.96M
754.14%8.86M
514.90%8.24M
142.51%2.06M
341.98%5.08M
115.66%320K
Non-operating interest income
56.87%19.79M
62.15%19.37M
223.49%58.34M
107.16%18.04M
214.86%15.74M
403.47%12.61M
556.21%11.94M
72.05%18.03M
399.14%8.71M
173.62%5M
Non-operating interest expense
-4.82%3.57M
-4.21%3.55M
8.87%16.74M
81.47%5.5M
-19.23%3.78M
-2.69%3.76M
-2.71%3.7M
4.29%15.38M
-6.76%3.03M
20.90%4.68M
Total other finance cost
----
----
0.17%594K
----
----
----
----
0.00%593K
----
----
Other net income (expense)
-25.30%-4.53M
181.13%11.27M
-110.38%-10.54M
-643.56%-6.84M
672.42%4.05M
6.08%-3.61M
-113.25%-13.89M
2,540.41%101.55M
529.35%1.26M
-109.68%-707K
Special income (charges)
--0
--10M
--0
--0
--0
--0
--0
1,395.00%103.6M
64.71%-600K
50.00%-900K
-Less：Restructuring and merger&acquisition
----
----
--0
--0
--0
----
----
-45.00%4.4M
-64.71%600K
-50.00%900K
-Gain on sale of property,plant,equipment
--0
--10M
--0
--0
--0
--0
--0
--108M
--0
--0
Other non- operating income (expenses)
-25.30%-4.53M
109.12%1.27M
-414.05%-10.54M
-468.03%-6.84M
1,996.89%4.05M
-22.60%-3.61M
-1,103.38%-13.89M
-117.31%-2.05M
32.05%1.86M
-97.88%193K
Income before tax
86.61%132.14M
85.96%105.55M
26.07%188.56M
210.08%19.33M
2,288.50%41.67M
103.18%70.81M
-57.70%56.76M
298.51%149.58M
73.63%-17.56M
95.88%-1.9M
Income tax
69.00%24.96M
185.94%16.89M
160.99%20.92M
93.95%-1.05M
-72.81%1.29M
105.51%14.77M
-55.90%5.91M
171.12%8.02M
-99.50%-17.31M
149.12%4.75M
Net income
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
Net income continuous Operations
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
Minority interest income
Net income attributable to the parent company
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
Basic earnings per share
86.67%0.56
74.07%0.47
17.11%0.89
8,315.09%0.11
625.00%0.21
100.00%0.3
-59.09%0.27
317.14%0.76
99.58%-0.0013
80.00%-0.04
Diluted earnings per share
89.66%0.55
70.37%0.46
16.00%0.87
8,315.09%0.11
625.00%0.21
93.33%0.29
-57.14%0.27
314.29%0.75
99.58%-0.0013
80.00%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M23.63%505.34M
Operating revenue 19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M23.63%505.34M
Cost of revenue -0.12%130.46M-7.60%125.18M6.45%514.85M6.43%135.48M7.27%124.75M6.09%130.62M15.82%135.47M2.80%483.67M6.30%127.29M12.32%116.29M
Gross profit 25.16%581.57M13.60%523.65M18.11%1.9B24.49%510.73M17.36%456.58M13.15%464.66M14.55%460.94M17.20%1.61B24.29%410.25M27.47%389.06M
Operating expense 15.54%461.12M11.71%445.19M11.48%1.75B14.35%496.45M10.37%431.01M7.68%399.09M7.40%398.54M8.02%1.57B10.11%434.15M9.52%390.53M
Selling and administrative expenses 27.62%263.03M7.05%225.91M9.75%937.3M11.93%275M3.32%224M4.71%206.1M8.43%211.02M12.46%854M12.91%245.7M18.28%216.8M
-Selling and marketing expense 6.23%122.8M----8.46%488.4M6.90%133.2M9.52%121.9M5.67%115.6M----11.16%450.3M10.17%124.6M14.74%111.3M
-General and administrative expense 54.95%140.23M----11.20%448.9M17.09%141.8M-3.22%102.1M3.51%90.5M----13.94%403.7M15.89%121.1M22.25%105.5M
Research and development costs 3.62%183.79M19.29%204.99M14.96%746.77M19.39%206.25M21.22%191.31M12.12%177.36M6.85%171.85M3.31%649.61M7.24%172.75M-0.03%157.83M
Depreciation amortization depletion -8.48%14.3M-8.76%14.3M-0.96%62.2M-3.18%15.2M-1.26%15.7M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M3.25%15.9M
-Depreciation and amortization -8.48%14.3M-8.76%14.3M-0.96%62.2M-3.18%15.2M-1.26%15.7M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M3.25%15.9M
Operating profit 83.71%120.45M25.73%78.46M243.96%158.1M159.74%14.28M1,835.91%25.57M63.70%65.57M99.20%62.4M161.84%45.96M62.79%-23.9M97.13%-1.47M
Net non-operating interest income expense 83.03%16.21M91.97%15.82M1,886.63%41M134.97%11.95M3,637.81%11.96M754.14%8.86M514.90%8.24M142.51%2.06M341.98%5.08M115.66%320K
Non-operating interest income 56.87%19.79M62.15%19.37M223.49%58.34M107.16%18.04M214.86%15.74M403.47%12.61M556.21%11.94M72.05%18.03M399.14%8.71M173.62%5M
Non-operating interest expense -4.82%3.57M-4.21%3.55M8.87%16.74M81.47%5.5M-19.23%3.78M-2.69%3.76M-2.71%3.7M4.29%15.38M-6.76%3.03M20.90%4.68M
Total other finance cost --------0.17%594K----------------0.00%593K--------
Other net income (expense) -25.30%-4.53M181.13%11.27M-110.38%-10.54M-643.56%-6.84M672.42%4.05M6.08%-3.61M-113.25%-13.89M2,540.41%101.55M529.35%1.26M-109.68%-707K
Special income (charges) --0--10M--0--0--0--0--01,395.00%103.6M64.71%-600K50.00%-900K
-Less：Restructuring and merger&acquisition ----------0--0--0---------45.00%4.4M-64.71%600K-50.00%900K
-Gain on sale of property,plant,equipment --0--10M--0--0--0--0--0--108M--0--0
Other non- operating income (expenses) -25.30%-4.53M109.12%1.27M-414.05%-10.54M-468.03%-6.84M1,996.89%4.05M-22.60%-3.61M-1,103.38%-13.89M-117.31%-2.05M32.05%1.86M-97.88%193K
Income before tax 86.61%132.14M85.96%105.55M26.07%188.56M210.08%19.33M2,288.50%41.67M103.18%70.81M-57.70%56.76M298.51%149.58M73.63%-17.56M95.88%-1.9M
Income tax 69.00%24.96M185.94%16.89M160.99%20.92M93.95%-1.05M-72.81%1.29M105.51%14.77M-55.90%5.91M171.12%8.02M-99.50%-17.31M149.12%4.75M
Net income 91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M
Net income continuous Operations 91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M
Minority interest income
Net income attributable to the parent company 91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M
Basic earnings per share 86.67%0.5674.07%0.4717.11%0.898,315.09%0.11625.00%0.21100.00%0.3-59.09%0.27317.14%0.7699.58%-0.001380.00%-0.04
Diluted earnings per share 89.66%0.5570.37%0.4616.00%0.878,315.09%0.11625.00%0.2193.33%0.29-57.14%0.27314.29%0.7599.58%-0.001380.00%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data